Ads
related to: otc drug
Search results
Senate Republicans block consideration of bill to create a ‘right to contraception’
The Hill· 3 days agoSenate Republicans on Wednesday blocked consideration of legislation that would create a federal...
...Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting - Innovent Biologics...
Benzinga· 7 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
From an Era of Well-washing to Championing the 50-plus Consumer, 9 Takeaways From WSL Strategic...
WWD via Yahoo News· 2 days agoWith this focus on community, there has also been an increased demand for engaging, wellness-centric...
... Global Cannabis Platform Embraced By Big Sponsors Like Adidas And Crocs - adidas (OTC:ADDYY),...
Benzinga· 6 days agoIt was the year 2013 and Santiago, Chile’s capital, was unknowingly about to become the epicenter of...
...of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer...
Benzinga· 7 days agoSAN FRANCISCO, U.S. and SUZHOU, China , June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes
GenSight Biologics Appoints William Monteith to its Board of Directors - Gensight Biologics (OTC...
Benzinga· 5 days agoGenSight Biologics (SIGHTGSGTF PEA-PME eligible)) SIGHT, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central ...
Medunik USA's UNIK Support Program for Pheburane® expands to now include 2 specialty pharmacy...
StreetInsider· 4 days agoUNIK Support offers specialized services to benefit patients including a copay savings program, patient care liaison services, mail order pharmacy and other support services. has recently added ...
Arcturus reports positive ARCT-032 cystic fibrosis data By Investing.com
Investing.com· 21 hours agoArcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (NASDAQ: ARCT), a biotechnology company...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks· 5 days agoFree Report) issued a statement disagreeing with the ruling by a state court in Delaware to allow jury trials for cases, which claim GSK’s discontinued heartburn drug Zantac ...
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
Benzinga· 3 days agoNew data from the ELATIVE® Phase III trial show 70% of patients treated with elafibranor achieved composite endpoint of slowing disease progression measured by biochemical response after 78-weeksData from the itch